会员登录.getTime()%>)
购物车()
首页>
生物试剂
成功收藏产品
商家描述
产品评价(0)
Nuwacell® hiPSC/hESC高效冻存液是化学成分明确，无血清配方，且无动物源成分的即用型临床级/药品级冻存保护液。保证细胞未分化状态和扩增能力的同时，大大降低了冻存过程中冰晶对细胞的损伤，有效提高细胞复苏效率和活率。
优势：
✔ 无血清、无动物源成分、化学成分明确；
✔ 自主化、国产化的原研体系；供货稳定，高性价比；
✔ 支持临床级/药品级细胞培养，培养的iPSC细胞通过了中国食品药品检定研究院质量复核；iPSC来源功能药物通过了IND默示许可。
引用文献：
Establishment of an induced pluripotent stem cell line from a patient with hereditary transthyretin amyloidosis carrying transthyretin (TTR) mutation p.Phe53Val
2020. He Shan, et al. Stem Cell Research(IF 1.587).
Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation
2020. He Shan , et al. Stem Cell Research(IF 1.587).
Generation of an induced pluripotent stem cell (iPSC) line (THSJTUi001-A) from a Wilson's disease patient harboring a homozygous Arg778Leu mutation in ATP7B gene
2020. Wang, Shu Hong , et al. Stem Cell Research(IF 1.587).
优势：
✔ 无血清、无动物源成分、化学成分明确；
✔ 自主化、国产化的原研体系；供货稳定，高性价比；
✔ 支持临床级/药品级细胞培养，培养的iPSC细胞通过了中国食品药品检定研究院质量复核；iPSC来源功能药物通过了IND默示许可。
引用文献：
Establishment of an induced pluripotent stem cell line from a patient with hereditary transthyretin amyloidosis carrying transthyretin (TTR) mutation p.Phe53Val
2020. He Shan, et al. Stem Cell Research(IF 1.587).
Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation
2020. He Shan , et al. Stem Cell Research(IF 1.587).
Generation of an induced pluripotent stem cell (iPSC) line (THSJTUi001-A) from a Wilson's disease patient harboring a homozygous Arg778Leu mutation in ATP7B gene
2020. Wang, Shu Hong , et al. Stem Cell Research(IF 1.587).